Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

267 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease.
Ridet JL, Bensadoun JC, Déglon N, Aebischer P, Zurn AD. Ridet JL, et al. Among authors: aebischer p. Neurobiol Dis. 2006 Jan;21(1):29-34. doi: 10.1016/j.nbd.2005.06.003. Epub 2005 Jul 14. Neurobiol Dis. 2006. PMID: 16023352
Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina.
Kostic C, Chiodini F, Salmon P, Wiznerowicz M, Deglon N, Hornfeld D, Trono D, Aebischer P, Schorderet DF, Munier FL, Arsenijevic Y. Kostic C, et al. Among authors: aebischer p. Gene Ther. 2003 May;10(9):818-21. doi: 10.1038/sj.gt.3301948. Gene Ther. 2003. PMID: 12704422
Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts.
Déglon N, Heyd B, Tan SA, Joseph JM, Zurn AD, Aebischer P. Déglon N, et al. Among authors: aebischer p. Hum Gene Ther. 1996 Nov 10;7(17):2135-46. doi: 10.1089/hum.1996.7.17-2135. Hum Gene Ther. 1996. PMID: 8934227
Encapsulated cell implants as a novel treatment for Parkinson's disease.
Tseng JL, Aebischer P. Tseng JL, et al. Among authors: aebischer p. Methods Mol Med. 2001;62:279-88. doi: 10.1385/1-59259-142-6:279. Methods Mol Med. 2001. PMID: 21318783
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.
Bloch J, Bachoud-Lévi AC, Déglon N, Lefaucheur JP, Winkel L, Palfi S, Nguyen JP, Bourdet C, Gaura V, Remy P, Brugières P, Boisse MF, Baudic S, Cesaro P, Hantraye P, Aebischer P, Peschanski M. Bloch J, et al. Among authors: aebischer p. Hum Gene Ther. 2004 Oct;15(10):968-75. doi: 10.1089/hum.2004.15.968. Hum Gene Ther. 2004. PMID: 15585112 Clinical Trial.
Survival of encapsulated human primary fibroblasts and erythropoietin expression under xenogeneic conditions.
Schwenter F, Schneider BL, Pralong WF, Déglon N, Aebischer P. Schwenter F, et al. Among authors: aebischer p. Hum Gene Ther. 2004 Jul;15(7):669-80. doi: 10.1089/1043034041361172. Hum Gene Ther. 2004. PMID: 15242527
Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.
Régulier E, Pereira de Almeida L, Sommer B, Aebischer P, Déglon N. Régulier E, et al. Among authors: aebischer p. Hum Gene Ther. 2002 Nov 1;13(16):1981-90. doi: 10.1089/10430340260355383. Hum Gene Ther. 2002. PMID: 12427308
Lentiviruses as vectors for CNS diseases.
Déglon N, Aebischer P. Déglon N, et al. Among authors: aebischer p. Curr Top Microbiol Immunol. 2002;261:191-209. doi: 10.1007/978-3-642-56114-6_10. Curr Top Microbiol Immunol. 2002. PMID: 11892248 Review. No abstract available.
Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.
de Almeida LP, Zala D, Aebischer P, Déglon N. de Almeida LP, et al. Among authors: aebischer p. Neurobiol Dis. 2001 Jun;8(3):433-46. doi: 10.1006/nbdi.2001.0388. Neurobiol Dis. 2001. PMID: 11442352
Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2.
Azzouz M, Hottinger A, Paterna JC, Zurn AD, Aebischer P, Büeler H. Azzouz M, et al. Among authors: aebischer p. Hum Mol Genet. 2000 Mar 22;9(5):803-11. doi: 10.1093/hmg/9.5.803. Hum Mol Genet. 2000. PMID: 10749988
267 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback